FDA Inspection 1193371 — Emory Reproductive Center

Emory Reproductive Center — FEI 3003935810

The FDA completed an inspection of Emory Reproductive Center on November 15, 2022 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)